Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Anglo-French Drugs & Industries Limited
Location
T. Score
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
People
Network
Registered Details

ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED

www.afdil.com

Active

Updated: 21 Oct 2024

Anglo-French Drugs & Industries Limited, is an unlisted public company incorporated on 01 February, 1923. It is classified as a public limited company and is located in Bangalore, Karnataka. It's authorized share capital is INR 2.00 cr and the total paid-up capital is INR 1.23 cr.

Anglo-French Drugs & Industries Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 606.36% over the previous year. At the same time, it's book networth has increased by 1032.45%.

Industry

Manufacturing of Pharmaceuticals

Products

PANOXEN Tablets, NITRAVET 5 MG Tablets, AFDICOLD Tablets, Episeize, Beplex Elixir Plus Liquid, DIAZEPAM 5 MG Tablets, Phenyton-Tablets, MAXIMIN FORTE Tablets, AFD Multivitamin Tablets, BEPLEX FORTE Tablets, BEPLEX Tablets

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue

-9.32%

₹ GET PRO

EBITDA

₹ GET PRO

Net Profit

-106.46%

₹ GET PRO

Networth

-18.17%

₹ GET PRO

Borrowings

-65.39%

₹ GET PRO

Assets

-19.52%

₹ GET PRO

Gross Margin

3.72

GET PRO %

Operating Margin

27.83

GET PRO %

Net Profit Margin

-185.78

GET PRO %

Return on Equity

-98.65

GET PRO %

ROCE

10.44

GET PRO %

Debt to Equity

-0.07

GET PRO

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

View subscriptions and buy credits

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (24)

State	Type	Address

Locations on Map

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Financial Highlights

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Equity Capital	1.2	1.2	1.2	1.3	1.3
Reserves	3.5	2.8	5.3	14.8	17.6
Borrowings +	46.8	45.3	40.0	39.7	35.1
Long term borrowings	8.9	7.3	9.3	16.5	20.3
Short term borrowings	37.9	38.0	30.7	23.2	14.8
Trade payables +	32.5	25.6	28.6	22.6	22.4
Days payable	189.0	147.0	178.0	112.0	104.0
Other liabilities +	54.3	44.5	47.0	39.0	43.0
Other non-current liabilities	3.6	4.1	4.3	4.5	9.9
Other current liabilities	18.3	14.7	14.0	11.9	10.7
Total liabilities	105.8	93.7	93.5	94.8	97.1
Fixed Assets +	15.8	14.8	15.3	13.6	18.8
Tangible assets	15.8	14.8	15.3	13.6	18.7
CWIP	-	-	-	-	-
Intangible assets	-	-	-	-	-
LT loans and advances	-	-	-	-	-
Other non-current assets	1.4	1.4	1.2	0.6	0.4
Current assets +	88.6	77.6	76.9	80.6	77.9
Inventories	40.6	39.8	42.8	36.7	32.8
Trade receivables	28.3	29.5	25.8	36.3	34.3
Cash and cash equivalents	2.0	0.2	0.2	0.6	0.5
ST loans and advances	-	-	-	-	-
Other current assets	17.6	8.0	8.1	7.0	10.4
Total assets	105.8	93.7	93.5	94.8	97.1

Percentage of assets	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Equity Capital	1.1	1.24	1.24	1.36	1.33
Reserves	3.3	2.98	5.72	15.6	18.16
Borrowings +	44.25	48.34	42.79	41.9	36.19
Long term borrowings	8.45	7.83	9.92	17.38	20.93
Short term borrowings	35.81	40.51	32.88	24.52	15.26
Trade payables	30.7	27.36	30.65	23.81	23.11
Other liabilities +	51.35	47.44	50.24	41.14	44.32
Other non-current liabilities	3.37	4.42	4.56	4.8	10.19
Other current liabilities	17.27	15.67	15.03	12.53	11.03
Total liabilities
Fixed Assets +	14.96	15.79	16.38	14.36	19.32
Tangible assets	14.93	15.74	16.34	14.33	19.29
CWIP	0.0	0.0	0.0	0.0	0.0
Intangible assets	0.03	0.05	0.04	0.03	0.03
LT loans and advances	0.0	0.0	0.0	0.0	0.0
Other non-current assets	1.33	1.45	1.33	0.59	0.42
Current assets +	83.71	82.76	82.29	85.05	80.26
Inventories	38.41	42.47	45.78	38.69	33.75
Trade receivables	26.76	31.47	27.61	38.26	35.28
Cash and cash equivalents	1.86	0.23	0.25	0.68	0.51
ST loans and advances	0.0	0.0	0.0	0.0	0.0
Other current assets	16.67	8.58	8.66	7.42	10.71
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Sales growth %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Sales +	111.4	129.1	130.2	153.8	165.3
Sales growth %	None	15.92	0.81	18.13	7.5
Expenses +	125.3	130.7	126.5	145.2	163.9
Cost of goods	62.9	63.8	58.8	73.7	79.1
Employee cost	23.9	23.5	24.2	27.2	29.0
Other costs	32.5	34.9	34.9	36.5	48.7
Operating profit +	-7.8	6.9	12.4	16.4	8.6
Operating margin %	-7.0	5.4	9.5	10.6	5.2
Other income	1.0	0.7	1.6	1.0	0.8
Interest	4.3	6.8	6.2	5.3	4.3
Depreciation	1.8	1.7	2.5	2.5	2.9
Exceptional items	-	-	-1.6	-	-
Profit before tax	-12.9	-0.8	3.7	9.6	2.2
Tax	-1.7	-	0.6	2.1	0.4
Profit - disc. ops	-	-	-	-	-
Net profit	-11.2	-0.8	3.1	7.5	1.9
Net margin %	-10.0	-0.7	2.4	4.8	1.1

Precentage of total income	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Sales	99.1	99.46	98.82	99.34	99.51
Expenses +	111.48	100.65	96.04	93.78	98.65
Cost of goods	55.93	49.14	44.61	47.61	47.61
Employee cost	21.23	18.08	18.35	17.58	17.44
Other costs	28.92	26.89	26.46	23.58	29.29
Operating profit	-6.97	5.35	9.4	10.57	5.17
Other income	0.9	0.54	1.18	0.66	0.49
Interest	3.82	5.21	4.68	3.42	2.57
Depreciation	1.59	1.33	1.93	1.59	1.75
Exceptional items	0.0	0.0	-1.18	0.0	0.0
Profit before tax	-11.48	-0.65	2.78	6.22	1.35
Tax	-1.49	0.0	0.42	1.37	0.22
Profit - disc. ops	0.0	0.0	0.0	0.0	0.0
Net profit	-10.0	-0.65	2.36	4.85	1.13

Revenue from operations

Ratios

Standalone

Consolidated

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Debt/Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Assets/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Liquidity +
Current Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Quick Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest Coverage	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Performance
Gross Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return +
Return on Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROCE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return on Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROIC	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Efficiency +
Days Payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Inventory	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Receivable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital
Cash Conversion Cycle	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital Days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Solvency +
Total Debt/Equity	10.1	11.5	6.1	2.5	1.9
Net Debt/Equity	9.6	11.4	6.1	2.4	1.8
Total Debt/Assets	0.4	0.5	0.4	0.4	0.4
Total Assets/Equity	22.7	23.7	14.3	5.9	5.1
Liquidity +
Current Ratio	1.0	1.0	1.1	1.4	1.6
Quick Ratio	0.5	0.5	0.5	0.8	0.9
Interest Coverage	-1.8	1.0	2.0	3.1	2.0
Performance
Gross Margin	43.6	50.6	54.9	52.1	52.1
Operating Margin	-7.0	5.4	9.5	10.6	5.2
Net Margin	-10.0	-0.7	2.4	4.8	1.1
Return +
Return on Equity	-241.6	-21.5	47.8	46.7	9.9
Pre-tax ROCE	-61.1	37.0	52.3	38.0	11.7
Return on Assets	-10.6	-0.9	3.3	7.9	1.9
Pre-tax ROIC	-19.4	10.6	21.3	25.2	10.6
Efficiency +
Days Payable	189.0	147.0	178.0	112.0	104.0
Days Inventory	236.0	228.0	266.0	182.0	151.0
Days Receivable	93.0	83.0	72.0	86.0	76.0
Fixed Asset Turnover	7.0	8.7	8.5	11.3	8.8
Total Asset Turnover	1.1	1.4	1.4	1.6	1.7
Working Capital
Cash Conversion Cycle	140.0	164.0	160.0	156.0	123.0
Working Capital Days	0.0	-2.0	10.0	54.0	66.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

Bank wise

Charges

HDFC Bank Limited

No. of Loans: 1

Total Amount : 30.0 cr

Yes Bank Limited

No. of Loans: 1

Total Amount : 13.7 cr

Axis Bank Limited

No. of Loans: 1

Total Amount : 0.1 cr

Charge Holder	Amount	Date of creation/modification
HDFC Bank Limited	30.0 cr	12 Aug, 2024
Yes Bank Limited	13.7 cr	07 Apr, 2022
Axis Bank Limited	0.1 cr	23 Sep, 2019

Charges

HDFC Bank Limited

Yes Bank Limited

Axis Bank Limited

People

Designation	Name	DIN/PAN	Tenure
Managing Director	Abhay Kanoria	00108894	28 years
Whole-time Director	Uddhav Abhay Kanoria	00108909	19 years
Whole-time Director	Nirbhay Abhay Kanoria	02558300	1 years
Director	Pradeep Joshi	02713934	1 years
Director	Rohit Choraria	07003583	2 years
Director	Rakesh Parmeshwar Kanyadi	08532438	6 years
Director	Srinivasan Krishnan	08709528	1 years
Director	Rani Shokeen	10634071	1 years
Kmp	Manee Sriee Aneetha	<HIDDEN>	3 years
Kmp	Manik Kumar Singh	<HIDDEN>	1 years

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
BROACH TEXTILE MILLS LIMITED (FULLFLEDGED PUBLIC CO )	Active	8.9 Cr	2	Maharashtra
RADHA KESARI SPINNING MILLS LIMITED	Active	8.5 L	1	Gujarat
SUDARSHAN EXPORTS LTD	Strike Off	49.5 L	1	West Bengal
THAMES LINERS LTD	Strike Off	24.5 L	1	West Bengal
BROACH PROCESSORS PVT LTD	Amalgamated	50.5 L	2	Maharashtra
TIRUPATI PRINTERS PVT LTD	Amalgamated	50.5 L	2	Maharashtra
SUDARSHAN EXPORTS LIMITED	Active	32.8 L	2	Maharashtra
EKTA TIE-UP PRIVATE LIMITED	Active	1.6 Cr	2	Maharashtra
SHRI BINOD KANORIA FOUNDATION	Active	10,000.0	2	Maharashtra
PARITOSH INDUSTRIAL FINANCE LIMITED	Amalgamated	50.0 L	1	Maharashtra
ENTREPRENEURS' ORGANIZATION MUMBAI	Active	0.0	1	Maharashtra
AFD PHARMA PRIVATE LIMITED	Active	17.0 L	1	Maharashtra
BALA MANDIR FOUNDATION	Active	0.0	1	Tamil Nadu

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
Anglo French Drugs & Industries Pte. Ltd.	Singapore	-	-

Registered Details

CIN

L24230KA1923PLC010205

PAN

AAACA9756E

Incorporation

1923, 102.3 years

Company Email

compliance@afdil.com

Paid up Capital

₹ 1.2 Cr

Authorised Capital

₹ 2.0 Cr

AGM

Aug 2024

Type

Public

Non-government Company

FAQ - ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED

What is the incorporation date of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED?

The incorporation date of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED is 01 February, 1923

What is the authorized share capital of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED?

The authorized share capital of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED is INR ₹ 2.0 Cr.

What is the paid-up capital of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED?

The paid-up capital of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED is INR ₹ 1.2 Cr.

What is the registered address of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED?

The registered address of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED is Plot No.4 Phase II, Peenya Industrial Area, Peenya Peenya Sm all Industries Bangalore North Bangalore Karnataka - 560058

What is the CIN number of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED?

The CIN number of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED is L24230KA1923PLC010205.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Industry

Buy Report or Plans

Dashboards

Company dashboard

View subscriptions and buy credits

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

Tofler Score

Risk

About Tofler Score

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Charges

People

Company Network